Skip to main navigation Skip to search Skip to main content

Myeloperoxidase inhibitor AZD4831 target engagement and safety in a phase 2a study in patients with heart failure with preserved ejection fraction (SATELLITE)

  • C. S. P. Lam
  • , A. A. Voors
  • , S. J. Shah
  • , D. Erlinge
  • , A. Saraste
  • , C. Pirazzi
  • , E. L. Grove
  • , A. Barasa
  • , M. Schou
  • , A. Aziz
  • , A. Gustavsson
  • , P. Garkaviy
  • , L. M. Gan
  • , A. Gabrielsen
  • , L. H. Lund
  • Northwestern University Feinberg School of Medicine
  • Hillerød Hospital
  • Karolinska Institute
  • AstraZeneca
  • Glostrup Hospital
  • Duke University
  • National University of Singapore
  • University of Groningen
  • Skåne University Hospital
  • Turku University Hospital
  • Sahlgrenska University Hospital
  • Aarhus University Hospital

Research output: Contribution to journalConference abstract in journalResearchpeer-review

Original languageEnglish
JournalEuropean Journal of Heart Failure
Volume23
Issue numberSuppl. 2
Pages (from-to)129-130
Number of pages2
ISSN1388-9842
Publication statusPublished - Sept 2021
EventHeart Failure 2021 and the World Congress on Acute Heart Failure: Online Congress -
Duration: 29. Jun 20211. Jul 2021

Conference

ConferenceHeart Failure 2021 and the World Congress on Acute Heart Failure
Period29/06/202101/07/2021

Cite this